{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:01:01Z","timestamp":1778072461158,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019081","name":"Aerie Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ajo.2023.04.017","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T01:33:10Z","timestamp":1682991190000},"page":"295-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-4711","authenticated-orcid":false,"given":"Sasan","family":"Moghimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-9187","authenticated-orcid":false,"given":"Alireza","family":"Kamalipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-6623","authenticated-orcid":false,"given":"Takashi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Zangwill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-089X","authenticated-orcid":false,"given":"Massimo","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Girkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-0533","authenticated-orcid":false,"given":"Jeffrey M.","family":"Liebmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-3202","authenticated-orcid":false,"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ajo.2023.04.017_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2023.04.017_bib0002","doi-asserted-by":"crossref","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.ajo.2023.04.017_bib0003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/ICU.0b013e32832401a9","article-title":"Glaucoma and disability: which tasks are affected, and at what stage of disease?","volume":"20","author":"Ramulu","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.04.017_bib0004","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1167\/iovs.07-1609","article-title":"Glaucoma and on-road driving performance","volume":"49","author":"Haymes","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"23","key":"10.1016\/j.ajo.2023.04.017_bib0005","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.visres.2010.05.021","article-title":"Vision and driving","volume":"50","author":"Owsley","year":"2010","journal-title":"Vision Res"},{"issue":"1","key":"10.1016\/j.ajo.2023.04.017_bib0006","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archophthalmol.2008.523","article-title":"Glaucoma and reading speed: the Salisbury Eye Evaluation project","volume":"127","author":"Ramulu","year":"2009","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"3","key":"10.1016\/j.ajo.2023.04.017_bib0007","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.06-0886","article-title":"Risk of falls and motor vehicle collisions in glaucoma","volume":"48","author":"Haymes","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"315","key":"10.1016\/j.ajo.2023.04.017_bib0008","first-page":"5","article-title":"Are we ready to assess quality of life routinely in our glaucoma patients?","author":"Skalicky","year":"2010","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.04.017_bib0009","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/IJG.0b013e3181752c83","article-title":"Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire","volume":"18","author":"Goldberg","year":"2009","journal-title":"J Glaucoma"},{"issue":"6","key":"10.1016\/j.ajo.2023.04.017_bib0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ophtha.2007.08.037","article-title":"Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study","volume":"115","author":"McKean-Cowdin","year":"2008","journal-title":"Ophthalmology"},{"issue":"1 suppl","key":"10.1016\/j.ajo.2023.04.017_bib0011","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajo.2005.07.075","article-title":"Evaluation of quality of life for patients with glaucoma","volume":"141","author":"Spaeth","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2023.04.017_bib0012","first-page":"301","article-title":"Glaucoma patients' assessment of their visual function and quality of life","volume":"99","author":"Jampel","year":"2001","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"10.1016\/j.ajo.2023.04.017_bib0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jamaophthalmol.2013.2602","article-title":"Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma","volume":"131","author":"Lisboa","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.04.017_bib0014","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ophtha.2014.08.014","article-title":"Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients","volume":"122","author":"Medeiros","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.04.017_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2022.2140","article-title":"Association between ganglion cell complex thinning and vision-related quality of life in glaucoma","author":"Nishida","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.04.017_bib0016","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/eye.2010.133","article-title":"The relationship between visual field loss in glaucoma and health-related quality-of-life","volume":"24","author":"van Gestel","year":"2010","journal-title":"Eye (London, England)"},{"issue":"6","key":"10.1016\/j.ajo.2023.04.017_bib0017","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archopht.1997.01100150779014","article-title":"Influence of glaucomatous visual field loss on health-related quality of life","volume":"115","author":"Gutierrez","year":"1997","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"11","key":"10.1016\/j.ajo.2023.04.017_bib0018","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archopht.1997.01100160617016","article-title":"Visual function and quality of life among patients with glaucoma","volume":"115","author":"Parrish","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2023.04.017_bib0019","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ajo.2007.02.022","article-title":"Severity of visual field loss and health-related quality of life","volume":"143","author":"McKean-Cowdin","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.04.017_bib0020","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.ophtha.2013.07.020","article-title":"The relationship between better-eye and integrated visual field mean deviation and visual disability","volume":"120","author":"Arora","year":"2013","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2023.04.017_bib0021","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamaophthalmol.2017.1396","article-title":"Association between undetected 10-2 visual field damage and vision-related quality of life in patients with glaucoma","volume":"135","author":"Blumberg","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2023.04.017_bib0022","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajo.2018.07.011","article-title":"Macular damage, as determined by structure-function staging, is associated with worse vision-related quality of life in early glaucoma","volume":"194","author":"Garg","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.04.017_bib0023","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ophtha.2015.10.046","article-title":"The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma","volume":"123","author":"Abe","year":"2016","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2023.04.017_bib0024","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archophthalmol.2009.187","article-title":"The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data","volume":"127","author":"Sample","year":"2009","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"5","key":"10.1016\/j.ajo.2023.04.017_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archophthalmol.2010.58","article-title":"African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes","volume":"128","author":"Racette","year":"2010","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"8","key":"10.1016\/j.ajo.2023.04.017_bib0026","first-page":"2212","article-title":"Predicting binocular visual field sensitivity from monocular visual field results","volume":"41","author":"Nelson-Quigg","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2023.04.017_bib0027","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"11","key":"10.1016\/j.ajo.2023.04.017_bib0028","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"key":"10.1016\/j.ajo.2023.04.017_bib0029","series-title":"Rasch Analysis in the Human Sciences","author":"Boone","year":"2013"},{"key":"10.1016\/j.ajo.2023.04.017_bib0030","series-title":"Applying the Rasch Model: Fundamental Measurement in the Human Sciences","author":"Bond","year":"2013"},{"issue":"5","key":"10.1016\/j.ajo.2023.04.017_bib0031","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1586\/erp.11.59","article-title":"Rating scales and Rasch measurement","volume":"11","author":"Andrich","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"10.1016\/j.ajo.2023.04.017_bib0032","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1167\/iovs.09-4494","article-title":"The psychometric validity of the NEI VFQ-25 for use in a low-vision population","volume":"51","author":"Marella","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2023.04.017_bib0033","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archopht.123.6.815","article-title":"Self-reported comorbidities and visual function in a population-based study: the Los Angeles Latino Eye Study","volume":"123","author":"Globe","year":"2005","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"430","key":"10.1016\/j.ajo.2023.04.017_bib0034","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","article-title":"Bayes factors","volume":"90","author":"Kass","year":"1995","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"10.1016\/j.ajo.2023.04.017_bib0035","first-page":"1059","article-title":"Correlation of the binocular visual field with patient assessment of vision","volume":"43","author":"Jampel","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2023.04.017_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","article-title":"Ocular surface disease and quality of life in patients with glaucoma","volume":"153","author":"Skalicky","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.04.017_bib0037","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2023.04.017_bib0038","article-title":"Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension","author":"Baudouin","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.04.017_bib0039","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5301\/ejo.5000220","article-title":"Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients","volume":"23","author":"Rossi","year":"2013","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2023.04.017_bib0040","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2009.03.033","article-title":"Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project","volume":"116","author":"Ramulu","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2023.04.017_bib0041","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3341\/kjo.2002.16.2.70","article-title":"Visual function and quality of life in Korean patients with glaucoma","volume":"16","author":"Nah","year":"2002","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.04.017_bib0042","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1167\/iovs.08-2496","article-title":"The functional consequences of glaucoma for eye-hand coordination","volume":"50","author":"Kotecha","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2023.04.017_bib0043","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ajo.2009.12.028","article-title":"The assessment of disability related to vision performance-based measure in diabetic retinopathy","volume":"149","author":"Warrian","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.04.017_bib0044","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1167\/iovs.05-0750","article-title":"Visual field defects and the risk of motor vehicle collisions among patients with glaucoma","volume":"46","author":"McGwin","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2023.04.017_bib0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0161-6420(02)01742-6","article-title":"The relationship between visual disability and visual field in patients with glaucoma","volume":"110","author":"Sumi","year":"2003","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2023.04.017_bib0046","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2007.02.001","article-title":"Glaucoma and mobility performance: the Salisbury Eye Evaluation Project","volume":"114","author":"Friedman","year":"2007","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2023.04.017_bib0047","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.preteyeres.2007.08.001","article-title":"A framework for comparing structural and functional measures of glaucomatous damage","volume":"26","author":"Hood","year":"2007","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.ajo.2023.04.017_bib0048","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1167\/iovs.12-10345","article-title":"The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change","volume":"53","author":"Medeiros","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:54:43Z","timestamp":1757598883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":48,"alternative-id":["S0002939423001873"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.04.017","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}